The WHO Global Strategy for cervical cancer elimination launched in 2020 sets out a clear and ambitious goal, and represents an opportunity to improve outcomes and save lives through the implementation of effective, evidence-based interventions and innovative technologies, in particular in low and middle-income countries where 90% of deaths occur. The Strategy details that an estimated 10.5 billion USD is required to scale-up cervical cancer prevention and treatment to meet the 90:70:90 targets in the 78 countries most affected by cervical cancer. However, for every dollar invested, it is estimated that 3.20 USD will be returned to the economy.
This session highlights the key findings from the Economist Intelligence Unit’s recent report, ‘Global action on financing cervical cancer elimination: Funding secondary prevention services in low resource settings’, which was developed as part of the ‘Scale Up Cervical Cancer Elimination through Secondary prevention Strategies’ project, funded by Unitaid, and led by Expertise France, providing a high-level and global overview of global challenges and key priorities for the engagement of key stakeholders and decision makers on this topic. To explore this topic further, the session highlights regional and national examples and opportunities for the financing of cervical cancer elimination, including the possibility of regional partnerships and of Universal Health Coverage to reach the global targets and address the significant inequities that exist in the burden of this disease.
Speakers:
Clarito Jr Cairo – Medical Officer IV, Department of Health
Charlemagne Ouedraogo – Minister of Health, Ministry of Health of Burkina Faso
Rohit Sahgal – Principal Global Health, Asia, The Economist Group
Moderator:
Charles Goddard – Editorial Director, The Economist Group
